UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical characteristics of hepatocellular carcinoma in patients with cirrhosis: a comparative cohort study

Acta gastro-enterologica belgica, 2023-07, Vol.86 (3), p.412-416

2023

Volltextzugriff (PDF)

5-year mortality of alcohol-related cirrhosis: patients die just as much but not in the same manner

Acta gastro-enterologica belgica, 2022-07, Vol.85 (3), p.447-451

2022

Volltextzugriff (PDF)

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1170-1180

2018

Volltextzugriff (PDF)

The changing pattern of cirrhosis in Belgium: a study based on two cohorts prospectively collected 15 years apart

Acta gastro-enterologica belgica, 2020-10, Vol.83 (4), p.559

2020

Volltextzugriff (PDF)

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study

Endoscopy, 2012-11, Vol.44 (11), p.998-1008

2012

Volltextzugriff (PDF)

Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease

Acta gastro-enterologica belgica, 2022-04, Vol.85 (2), p.321-329

2022

Volltextzugriff (PDF)

Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients

Alimentary pharmacology & therapeutics, 2012-08, Vol.36 (4), p.353-362

2012

Volltextzugriff (PDF)

Statins and Clarithromycin : a dangerous combination. Case report and review of the literature

Acta gastro-enterologica belgica, 2019-01, Vol.82 (1), p.87-92

2019

Volltextzugriff (PDF)

Clinical Features and Outcomes According to the Etiology of Cirrhosis: A 20-Year Follow-Up Study in a Monocentric Cohort

Journal of hepatology, 2016, Vol.64 (2), p.S252-S253

2016

Volltextzugriff (PDF)

Archéologie du bâti. Aujourd’hui et demain

2022

Volltextzugriff (PDF)

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis

Liver international, 2005-04, Vol.25 (2), p.349-356

2005

Volltextzugriff (PDF)

Decompensated cirrhosis … are we gaining ground?

Acta clinica belgica (English ed. Online), 2013-11, Vol.68 (6), p.411-415

2013

Volltextzugriff (PDF)

HLA association of amoxicillin-clavulanate–induced hepatitis

Gastroenterology (New York, N.Y. 1943), 1999-11, Vol.117 (5), p.1181-1186

1999

Volltextzugriff (PDF)

Interferon-Free, Direct-Acting Antiviral Agents Regimens in Hepatitis C are more Effective, Better Tolerated, and Decrease Fatigue during Treatment in Real-Life Conditions

Journal of hepatology, 2016, Vol.64 (2), p.S743-S743

2016

Volltextzugriff (PDF)

Interferon-Free Treatment of Chronic Hepatitis C with Direct-Acting Antiviral Agents: Age is No Longer an Unfavorable Prognostic Factor

Journal of hepatology, 2016, Vol.64 (2), p.S742-S743

2016

Volltextzugriff (PDF)

Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinediones

Alimentary pharmacology & therapeutics, 2005-11, Vol.22 (10), p.897-905

2005

Volltextzugriff (PDF)

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Journal of hepatology, 2015-04, Vol.62, p.S213-S214

2015

Volltextzugriff (PDF)

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

Journal of medical virology, 2016-01, Vol.88 (1), p.94-99

2016

Volltextzugriff (PDF)

Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (4), p.454-461

2011

Volltextzugriff (PDF)

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Gastroenterology (New York, N.Y. 1943), 2016-05, Vol.150 (5), p.1147-1159.e5

2016

Volltextzugriff (PDF)

P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL

Journal of hepatology, 2014-04, Vol.60 (1), p.S448-S449

2014

Volltextzugriff (PDF)

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

Hepatology (Baltimore, Md.), 2014-06, Vol.59 (6), p.2170-2177

2014

Volltextzugriff (PDF)

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

Alimentary pharmacology & therapeutics, 2009-08, Vol.30 (4), p.352-363

2009

Volltextzugriff (PDF)

A three-dimensional plasma and energetic particle investigation for the wind spacecraft

Space science reviews, 1995-02, Vol.71 (1-4), p.125-153

1995

Volltextzugriff (PDF)

Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients

Alimentary pharmacology & therapeutics, 2009-08, Vol.30 (4), p.352-363

2009

Volltextzugriff (PDF)

1 – 25 von 1.252

Suche als RSS-Feed

Aktive Filter

ThemaPhysics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(887)
Mit Volltextzugriff
(827)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(378)
Science & Technology
(358)
Female
(277)
Life Sciences & Biomedicine
(263)
Male
(179)
Sciences Biologiques Et Medicales
(150)
Sciences Medicales
(148)
Pregnancy
(145)
Adult
(129)
Biological And Medical Sciences
(111)
Medical Sciences
(92)
Middle Aged
(89)
Gastroenterology & Hepatology
(83)
Animals
(82)
Life Sciences
(76)
Aged
(67)
Technology
(49)
Gynecologie. Andrologie. Obstetrique
(44)
Physical Sciences
(44)
Cardiovascular System & Cardiology
(42)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Clinical characteristics of hepatocellular carcinoma in patients with cirrhosis: a comparative cohort study

5-year mortality of alcohol-related cirrhosis: patients die just as much but not in the same manner

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

The changing pattern of cirrhosis in Belgium: a study based on two cohorts prospectively collected 15 years apart

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study

Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease

Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients

Statins and Clarithromycin : a dangerous combination. Case report and review of the literature

Clinical Features and Outcomes According to the Etiology of Cirrhosis: A 20-Year Follow-Up Study in a Monocentric Cohort

Archéologie du bâti. Aujourd’hui et demain

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis

Decompensated cirrhosis … are we gaining ground?

HLA association of amoxicillin-clavulanate–induced hepatitis

Interferon-Free, Direct-Acting Antiviral Agents Regimens in Hepatitis C are more Effective, Better Tolerated, and Decrease Fatigue during Treatment in Real-Life Conditions

Interferon-Free Treatment of Chronic Hepatitis C with Direct-Acting Antiviral Agents: Age is No Longer an Unfavorable Prognostic Factor

Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinediones

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

A three-dimensional plasma and energetic particle investigation for the wind spacecraft

Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients

Aktive Filter

Suchergebnisse filtern